Nanosphere Precision: Emulsomes Revolutionizing Cancer Targeted Therapy

Abstract

Emulsomes have gained attention because they are a novel lipoidal vesicular system that has an internal solid fat core surrounded by a phospholipid bilayer. Cancer is a complex and broad term that refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. In the context of cancer targeting, emulsomes have shown promising potential due to their ability to improve the solubility, stability, and bioavailability of anticancer drugs, leading to enhanced therapeutic efficacy and reduced systemic toxicity. This article addresses emulsomal composition, preparation techniques, and different kinds of emulsomes loaded with drugs like fluvastatin and raloxifene hydrochloride to target cancer cells. The use of emulsomes in cancer targeting holds great promise for improving the precision, efficacy, and safety of cancer treatments. A comprehensive search of relevant scientific literature was performed. This involved searching databases such as PubMed, Scopus, Web of Science, and others to identify relevant studies, articles, and reviews related to the topic. Emulsomes loaded with specific drugs show promising results in cancer treatment. Examples include piceatannol-loaded emulsomes for colon cancer, raloxifene hydrochloride-loaded emulsomes for breast cancer, and fluvastatin-loaded emulsomes for prostate cancer. Emulsomes represent a cutting-edge approach to cancer drug delivery, offering a versatile and effective solution to address challenges associated with traditional anticancer formulations. Ongoing research holds promise for the continued development of personalized cancer therapy.